The company
Evolent Health, Inc
EVH · NYSE
EVH stood above a rising 150-day average in 10 of the last 52 weekly readings, including each of the last 3 weeks. It is 19.4% above that average now. Professional Services: 33% of its 72 stocks in an uptrend (−1 points in four weeks); Industrials: 28% (−3 points in four weeks).
Statistics
- Rotation
- Just started moving
- Weeks in an uptrend
- 3 in a row
- Industry in uptrend
- 33% -1 in 4 wk
- Insider buys, 12 months
- $38K
- Insider sales, 12 months
- $659K
- Officials’ trades on record
- 7
- Institutions holding
- 188 (+10)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 10 of 52 weeks.
Professional Services: A minority of its stocks are in an uptrend and the share has held steady. Industrials: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
7 disclosed lines: House 7, Senate 0, executive 0; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Greg Gianforte House: U.S. House ClerkMT00 | sold | $50k–$100k | 11 May 2020filed 29 May 2020 |
| Greg Gianforte House: U.S. House ClerkMT00 | bought | $100k–$250k | 11 Oct 2019filed 27 Nov 2019 |
| Greg Gianforte House: U.S. House ClerkMT00 | sold | $50k–$100k | 10 Sep 2019filed 20 Oct 2019 |
| Greg Gianforte House: U.S. House ClerkMT00 | bought | $15k–$50k | 20 Dec 2018filed 23 Jan 2019 |
| Greg Gianforte House: U.S. House ClerkMT00 | bought | $50k–$100k | 7 Jun 2018filed 15 Jun 2018 |
| Greg Gianforte House: U.S. House ClerkMT00 | bought | $15k–$50k | 29 Jan 2018filed 8 Feb 2018 |
| Greg Gianforte House: U.S. House ClerkMT00 | sold | $15k–$50k | 29 Dec 2017filed 4 Jan 2018 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Daniel Joseph McCarthyPRESIDENT | sold | 65,892at $5.00 | 26 Aug 2026filed 28 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 14,814,851$80.3M | +3,925,979+36.1% |
| CADIAN CAPITAL MANAGEMENT, LPunchanged · filed 14 Aug 2026 | 10,814,473$58.6M | 00.0% |
| MORGAN STANLEYreduced · filed 13 Aug 2026 | 8,969,012$48.6M | -112,067−1.2% |
| UBS Group AGreduced · filed 13 Aug 2026 | 6,245,283$33.8M | -1,905,078−23.4% |
| Rubicon Founders LLCunchanged · filed 14 Aug 2026 | 5,816,123$31.5M | 00.0% |
| Engaged Capital LLCunchanged · filed 14 Aug 2026 | 5,563,912$30.2M | 00.0% |
| D. E. Shaw & Co., Inc.reduced · filed 14 Aug 2026 | 5,107,561$27.7M | -326,471−6.0% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 4,787,994$26.0M | -79,409−1.6% |
| MARSHALL WACE, LLPadded · filed 13 Aug 2026 | 3,413,245$18.5M | +2,628,233+334.8% |
| Nuveen, LLCadded · filed 11 Aug 2026 | 3,132,085$17.0M | +2,866,943+1081.3% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.